Rafferty Asset Management, LLC Cara Therapeutics, Inc. Transaction History

Rafferty Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$7.45 - $13.84 $79,044 - $146,842	10,610 New	10,610 $97,000
Q1 2022 May 13, 2022	SELL	$9.94 - $12.65 $141,018 - $179,465	-14,187 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$11.99 - $18.14 $170,102 - $257,352	14,187 New	14,187 $173,000
Q3 2019 Nov 14, 2019	SELL	$18.28 - $26.91 $1.78 Million - $2.62 Million	-97,268 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$17.68 - $21.57 $250,278 - $305,344	14,156 Added 17.03%	97,268 $2.09 Million

Q1 2019 May 15, 2019	BUY	$14.41 - $19.64 $1.2 Million - $1.63 Million	83,112 New	83,112 $1.63 Million

102

21.5M

50K

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $14M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Rafferty Asset Management, LLC with notifications on news.